%0 Journal Article
%T Desempenho do stent farmacol¨®gico firebird£¿ em diab¨¦ticos portadores de doen£¿a coron¨¢ria multiarterial
%A Osterne
%A Ernesto Misael Cintra
%A Pimentel Filho
%A Wilson Albino
%A Cust¨®dio
%A Wellington Borges
%A Petrucci
%A F¨¢bio Soares
%A Soares Neto
%A Milton Macedo
%A Maiello
%A Paulo C¨ªcero Aidar
%A Pupin Filho
%A Waigner Bento
%A Olivotti
%A Gustavo Vinicius Lambert
%A Sada
%A Carlos Alberto
%A Nunes
%A C¨¢ssio dos Santos
%A B¨¹chler
%A Jorge Roberto
%A Assis
%A Stoessel Figueredo de
%A Armelin
%A Egas
%J Revista Brasileira de Cardiologia Invasiva
%D 2012
%I Scientific Electronic Library Online
%R 10.1590/S2179-83972012000100012
%X background: preliminary data have shown the firebird£¿ and the cypher£¿ stents have similar safety and efficacy profiles. however, to date, no study has evaluated the percutaneous coronary intervention (pci) with the firebird£¿ stent in diabetic patients. methods: the performance of the firebird£¿ stent in diabetic patients with multivessel coronary artery disease (cad) (n = 100) was compared to that of the cypher£¿ stent, using historical data from the arts-ii study (n = 159). we compared the major adverse cardiovascular events (mace) at one year. results: most of the patients in the firebird£¿ group were male (65%), with mean age of 63.3 ¡À 10.4 years and 5% were receiving insulin. stable coronary syndromes were prevalent (60%), 45% had three-vessel cad and ventricular function was preserved (56.6 ¡À 13.7%). in patients with three-vessel cad, 135 lesions were treated with > 3 stents in 78% of the cases and 2 stents in the remaining ones. in patients with two-vessel cad, 110 lesions were treated with > 2 stents in 80% of the cases and 1 stent in the remaining ones. the incidence of mace at one year of the firebird£¿ stent was 21%, death was observed in 3% of the patients, myocardial infarction in 2% and a new revascularization procedure in 18%, predominantly at the expense of a new pci in 14% of the cases. comparison with the cypher£¿ group did not show differences for any of the evaluated endpoints. conclusions: in our study, the use of the firebird£¿ stent showed similar results to those of patients in the arts-ii study, which makes it attractive for use in the complex scenario of diabetic patients with multivessel cad.
%K coronary disease
%K angioplasty
%K drug-eluting stents
%K diabetes mellitus.
%U http://www.scielo.br/scielo.php?script=sci_abstract&pid=S2179-83972012000100012&lng=en&nrm=iso&tlng=en